Evidence map›Paper›PMID 33774104›Full record

ArticleAmerican journal of infection control2021

SARS-Cov-2 seroprevalence and risk factors among health care workers: Estimating the risk of COVID-19 dedicated units.

Maura Salaroli de Oliveira, Renata Desordi Lobo, Felippe Pires Detta, José Mauro Vieira-Junior, Thiago Lucas de Souza Castro, Daniella Bosco Zambelli, Luiz Francisco Cardoso, Igor Carmo Borges, Tânia Regina Tozetto-Mendoza, Silvia Figueiredo Costa and 1 more

Abstract read
In one paragraph

Article in American journal of infection control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maura Salaroli de OliveiraDepartment of Infection Control, Hospital Sírio Libanês, São Paulo, Brazil; Department of Infection Control, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Electronic address: masoliveira@hsl.org.br.
Renata Desordi LoboDepartment of Infection Control, Hospital Sírio Libanês, São Paulo, Brazil.
Felippe Pires DettaInstitute of Quality and Safety of Hospital Sírio Libanês, São Paulo, Brazil.
José Mauro Vieira-JuniorInstitute of Quality and Safety of Hospital Sírio Libanês, São Paulo, Brazil.
Thiago Lucas de Souza CastroHospital Sírio Libanês, São Paulo, Brazil.
Daniella Bosco ZambelliHospital Sírio Libanês, São Paulo, Brazil.
Luiz Francisco CardosoHospital Sírio Libanês, São Paulo, Brazil.
Igor Carmo BorgesDepartment of Infectious Diseases, Laboratório de Investigação Médica - LIM 49 (Bacteriology) and LIM-52 (Virology), Instituto de Medicina Tropical, University of São Paulo, Brazil.
Tânia Regina Tozetto-MendozaDepartment of Infectious Diseases, Laboratório de Investigação Médica - LIM 49 (Bacteriology) and LIM-52 (Virology), Instituto de Medicina Tropical, University of São Paulo, Brazil.
Silvia Figueiredo CostaDepartment of Infectious Diseases, Laboratório de Investigação Médica - LIM 49 (Bacteriology) and LIM-52 (Virology), Instituto de Medicina Tropical, University of São Paulo, Brazil.
Maria Cassia Mendes-CorreaDepartment of Infectious Diseases, Laboratório de Investigação Médica - LIM 49 (Bacteriology) and LIM-52 (Virology), Instituto de Medicina Tropical, University of São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the seroprevalence of SARS-CoV-2 and risk factors among 1,996 oligo/asymptomatic health care workers. The seroprevalence was 5.5% and risk factors associated with being infected with SARS-CoV-2 was professional category of cleaning (adj odds ratio 2.22, 95% confidence interval: 1.12-4.44, P: .023) and male gender (adj odds ratio: 1.54, 95% confidence interval: 1.03-2.32, P: .035).Working at dedicated COVID-19 units (high-risk group) was not an independent risk factor for seropositivity.

Indexed as

COVID-19SARS-CoV-2Health PersonnelHumansMaleRisk FactorsSeroepidemiologic StudiesCommunity transmissionOccupational riskSerology

Identifiers

PMID33774104
PMCPMC7989199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.